Skip to main content
. 2012 Sep;19(9):1509–1516. doi: 10.1128/CVI.00034-12

Fig 3.

Fig 3

Geometric mean fold rise (GMFR) by vaccine group through day 180 postvaccination. (A) Groups 1 and 2: 60-μg doses (without AAHSA). (B) Groups 3 and 4: 60-μg doses (with AAHSA). (C) Groups 5 and 6: 90-μg (with AAHSA) and placebo (PBO) doses. AAHSA, amorphous aluminum hydroxyphosphate sulfate adjuvant.